Gilead Sciences Inc (GILD)

GILD (NASDAQ:Drugs)
$75.18
pos +2.32
+3.18%
Today's Range: 73.91 - 75.88 | GILD Avg Daily Volume: 15,897,600
Last Update: 04/23/14 - 12:26 PM EDT
Volume: 21,060,403
YTD Performance: -4.66%
Open: $75.73
Previous Close: $72.86
52 Week Range: $46.70 - $84.88
Oustanding Shares: 1,538,252,914
Market Cap: 110,110,304,442
6-Month Chart
TheStreet Ratings Grade for GILD
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 16 17 16 16
Moderate Buy 2 2 2 2
Hold 1 1 1 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.21 1.20 1.21 1.30
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 42.97
Price Earnings Comparisons:
GILD Sector Avg. S&P 500
42.97 39.50 29.20
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-12.23% 37.03% 266.62%
GROWTH 12 Mo 3 Yr CAGR
Revenue 15.50 0.41 0.12
Net Income 18.80 0.06 0.02
EPS 121.60 0.18 0.06
Earnings for GILD:
EBITDA 4.87B
Revenue 11.20B
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $1.08 $1.20 $4.40 $8.83
Number of Analysts 2 2 2 1
High Estimate $1.33 $1.40 $5.19 $8.83
Low Estimate $0.82 $0.99 $3.61 $8.83
Prior Year $0.48 $0.50 $1.92 $4.40
Growth Rate (Year over Year) 123.96% 139.00% 129.17% 100.68%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Each distinct group of stocks has its own set of dynamics.

Mixing Growth With High Yield Real Money Pro($)

I am adding to plays with good gains at a reasonable price.
When people attach such frothy numbers to IPOs, we have problems.
Maybe we can get some perspective about stocks that were loved.
Some unexpected stocks and sectors have climbed the market's wall of worry.

The Market Digs Itself Out Real Money Pro($)

The indices are now hugging the flat line.
Algos think faster and react faster than humans can.
Let's categorize things in this vicious rotation.
Do you think I'm looking at yesterday's bloodbath as a buying opportunity?

Fitz Bits: The Biotech Wreck Real Money Pro($)

These stocks are broken -- and you can't un-break them

Columnist Conversations

Sanmina is up 15% on very heavy trade after the diversified electronics company reported better-than-expe...
If I were Netflix (NFLX) I would be looking at Amazon's (AMZN) new deal with HBO to stream their content with ...
Lang:
We added a few plays yesterday, mentioned here and see the results now. SWKS was a blowout qtr and reflected ...
Valmont Industries (VMI) reported slightly above estimate numbers for Q1 and guided in line with prior ranges ...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.